Clinical Research Directory
Browse clinical research sites, groups, and studies.
Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes
Sponsor: Kailera
Summary
The primary objective of the study is to determine the effects of ribupatide (KAI-9531) subcutaneous (SC) injection once weekly compared to placebo on percent change in body weight.
Official title: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of KAI-9531 Administered Once Weekly in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
2340
Start Date
2025-12-18
Completion Date
2028-03
Last Updated
2026-07-22
Healthy Volunteers
No
Conditions
Interventions
Ribupatide
SC Injection
Placebo
SC Injection
Locations (88)
Kailera Clinical Site
Anniston, Alabama, United States
Kailera Clinical Site
Birmingham, Alabama, United States
Kailera Clinical Site
Cullman, Alabama, United States
Kailera Clinical Site
Sun City, Arizona, United States
Kailera Clinical Site
Escondido, California, United States
Kailera Clinical Site
Toluca Lake, California, United States
Kailera Clinical Site
Aurora, Colorado, United States
Kailera Clinical Site
Bridgeport, Connecticut, United States
Kailera Clinical Site
Jupiter, Florida, United States
Kailera Clinical Site
Lilburn, Georgia, United States
Kailera Clinical Site
Springfield, Illinois, United States
Kailera Clinical Site
Columbia, Maryland, United States
Kailera Clinical Site
Las Vegas, Nevada, United States
Kailera Clinical Site
Rochester, New York, United States
Kailera Clinical Site
Morehead City, North Carolina, United States
Kailera Clinical Site
Chickasha, Oklahoma, United States
Kailera Clinical Site
Mauldin, South Carolina, United States
Kailera Clinical Site
Chattanooga, Tennessee, United States
Kailera Clinical Site
Amarillo, Texas, United States
Kailera Clinical Site
Bellaire, Texas, United States
Kailera Clinical Site
DeSoto, Texas, United States
Kailera Clinical Site
Tomball, Texas, United States
Kailera Clinical Site
Salt Lake City, Utah, United States
Kailera Clinical Site
Danville, Virginia, United States
Kailera Clinical Site
San Nicolás de los Arroyos, Buenos Aires, Argentina
Kailera Clinical Site
Buenos Aires, Buenos Aires F.D., Argentina
Kailera Clinical Site
Buenos Aires, Buenos Aires F.D., Argentina
Kailera Clinical Site
Buenos Aires, Buenos Aires F.D., Argentina
Kailera Clinical Site
Godoy Cruz, Mendoza Province, Argentina
Kailera Clinical Site
Rosario, Santa Fe Province, Argentina
Kailera Clinical Site
CABA, Argentina
Kailera Clinical Site
Córdoba, Argentina
Kailera Clinical Site
Silverdale, Auckland, Australia
Kailera Clinical Site
Charlestown, New South Wales, Australia
Kailera Clinical Site
Sydney, New South Wales, Australia
Kailera Clinical Site
Sydney, New South Wales, Australia
Kailera Clinical Site
Sydney, New South Wales, Australia
Kailera Clinical Site
Wollongong, New South Wales, Australia
Kailera Clinical Site
Sippy Downs, Queensland, Australia
Kailera Clinical Site
Norwood, South Australia, Australia
Kailera Clinical Site
Heidelberg Heights, Victoria, Australia
Kailera Clinical Site
Melbourne, Victoria, Australia
Kailera Clinical Site
Kyustendil, Kyustendil Province, Bulgaria
Kailera Clinical Site
Pazardzhik, Bulgaria
Kailera Clinical Site
Plovdiv, Bulgaria
Kailera Clinical Site
Plovdiv, Bulgaria
Kailera Clinical Site
Sofia, Bulgaria
Kailera Clinical Site
Sofia, Bulgaria
Kailera Clinical Site
Varna, Bulgaria
Kailera Clinical Site
Yambol, Bulgaria
Kailera Clinical Site
Brandýs nad Labem, Central Bohemia, Czechia
Kailera Clinical Site
Náchod, Hradec Králové Region, Czechia
Kailera Clinical Site
Brno, South Moravian, Czechia
Kailera Clinical Site
Hodonín, Czechia
Kailera Clinical Site
Uherské Hradiště, Czechia
Kailera Clinical Site
Falkensee, Brandenburg, Germany
Kailera Clinical Site
Cologne, North Rhine-Westphalia, Germany
Kailera Clinical Site
Essen, North Rhine-Westphalia, Germany
Kailera Clinical Site
Dresden, Saxony, Germany
Kailera Clinical Site
Leipzig, Saxony, Germany
Kailera Clinical Site
Oldenburg in Holstein, Schleswig-Holstein, Germany
Kailera Clinical Site
Hamburg, Germany
Kailera Clinical Site
Hamburg, Germany
Kailera Clinical Site
Schwerin, Germany
Kailera Clinical Site
Grafton, Auckland, New Zealand
Kailera Clinical Site
Hamilton, Waikato Region, New Zealand
Kailera Clinical Site
Auckland, New Zealand
Kailera Clinical Site
Nelson, New Zealand
Kailera Clinical Site
Torun, Kuyavian-Pomeranian Voivodeship, Poland
Kailera Clinical Site
Krakow, Lesser Poland Voivodeship, Poland
Kailera Clinical Site
Siedlce, Masovian Voivodeship, Poland
Kailera Clinical Site
Warsaw, Masovian Voivodeship, Poland
Kailera Clinical Site
Skierniewice, Poland
Kailera Clinical Site
Zamość, Poland
Kailera Clinical Site
Ferrol, A Coruna, Spain
Kailera Clinical Site
Villamartín, Cadiz, Spain
Kailera Clinical Site
Castilleja de la Cuesta, Sevilla, Spain
Kailera Clinical Site
Barcelona, Spain
Kailera Clinical Site
Madrid, Spain
Kailera Clinical Site
Valencia, Spain
Kailera Clinical Site
Soham, Cambridgeshire, United Kingdom
Kailera Clinical Site
Torpoint, Cornwall, United Kingdom
Kailera Clinical Site
Hull, East Yorkshire, United Kingdom
Kailera Clinical Site
Leicester, Leicestershire, United Kingdom
Kailera Clinical Site
Nottingham, Nottinghamshire, United Kingdom
Kailera Clinical Site
Hounslow, United Kingdom
Kailera Clinical Site
London, United Kingdom
Kailera Clinical Site
Manchester, United Kingdom